Researchers Receive $3.4 million to Study Experimental Drug Combination in HIV

Researchers at the University of Rochester Medical Center and University of Nebraska Medical Center have received a $3.4 million grant from the National Institutes of Health to study an experimental drug combination that appears to rid white blood cells of HIV and keep the infection in check for long periods. While current HIV treatments involve pills that are taken daily, the experimental drugs’ long-lasting effects suggest the possibility of an HIV treatment that could be administered monthly, or perhaps a few times a year.

Read More

The Entrepreneurs Network Seeks Applications

Rochester Business Journal
12 August 2014

The Entrepreneurs Network is soliciting applications for its 17th class, with sessions to begin next month.

The class will meet monthly at High Tech Rochester Inc. in Henrietta and other venues in the Rochester area beginning Sept. 18 and ending in December, officials said.

The class is limited to 15 members. The application deadline is Sept. 5. Upon acceptance, members pay an all-inclusive fee of $350.

Read more

Mapping the Optimal Route between Two Quantum States

Experiment measures millions of quantum trajectories to predict ‘most likely’ route
As a quantum state collapses from a quantum superposition to a classical state or a different superposition, it will follow a path known as a quantum trajectory. For each start and end state there is an optimal or “most likely” path, but it is not as easy to predict the path or track it experimentally as a straight-line between two points would be in our everyday, classical world.

Read More

43 North Announces Semi-Finalists (Spoiler: this is the fourth connected to UR technologies)

Recently, 113 semi-finalists were announced in the 2014 43 North $1 million business plan competition. Ten of those semi-finalists are from the Rochester area. Four of those are connected to University of Rochester technologies.

Health Care Originals (Rochester, NY) is negotiating a license for a safe, non-invasive, and accurate system to monitor asthma symptoms developed by Hyekyun Rhee, Ph.D. (Associate Professor in the School of Nursing) and Mark Bocko, Ph.D. (Professor in the Department of Electrical and Computer Engineering.

HCO won the Mark Ain Business Model Competition in 2013, and was recently named one of 40 semi-finalist s in the 2014 Make It Wearable Challenge by Intel (Development Track).

43 North Announces Semi-Finalists (Spoiler: this is #3 connected to UR technologies)

Recently, 113 semi-finalists were announced in the 2014 43 North $1 million business plan competition. Ten of those semi-finalists are from the Rochester area. Four of those are connected to University of Rochester technologies.

Ovitz Corporation (West Henrietta, NY) intends to develop and commercialize a portable wavefront sensor (a vision diagnosing device) invented by Geunyoung Yoon, Ph.D., an Associate Professor in the Department of Ophthalmology.

43 North Announces Semi-Finalists (Spoiler: this one’s connected to UR technologies, too)

Recently, 113 semi-finalists were announced in the 2014 43 North $1 million business plan competition. Ten of those semi-finalists are from the Rochester area. Four of those are connected to University of Rochester technologies.

Raland Therapeutics, Inc. (Fairport, NY) has licensed three technologies from the laboratory of Spencer Rosero, M.D., Associate Professor in the Department of Medicine (Cardiology Division). Raland has developed implantable cell-embedded biosensors that provide better, more physiologically relevant data to address needs in the preclinical R&D markets. They have integrated their core expertise in implantable biosensors for animals in the preclinical research space
with the long-term goal of addressing human disease.

43 North Announces Semi-Finalists (Spoiler: this one’s connected to UR technologies)

Recently, 113 semi-finalists were announced in the 2014 43 North $1 million business plan competition. Ten of those semi-finalists are from the Rochester area. Four of those are connected to University of Rochester technologies.

SmartDialysis (Rochester, NY) is trying to create a portable hemodialysis device to improve the lives of ESRD patients. The company has expressed interest in the possibility of licensing select technologies is interested in licensing two technologies from the laboratory of James McGrath, an Associate Professor in the Department of Biomedical Engineering.

Rochester Shines in First Round of 43 North Business Plan Competition

On 15 July 2014, nearly 7,000 applicants from 96 countries were winnowed down to 113 semi-finalists in the $1 Million 43 North Business Plan Competition. It is very exciting to see that ten of the semi-finalists are from the Greater Rochester Area! They are:

  1. Artwork Evolution
  2. Braverman Consulting
  3. Clerisy Corp
  4. Empire Genomics, LLC
  5. Energy Harvesters, LLC
  6. Health Care Originals
  7. Ovitz Corporation
  8. Raland Therapeutics, Inc.
  9. SmartDialysis
  10. TeraPore Technologies, Inc.

Congratulations! And Best Wishes going forward!

A New Look for Our Website

The UR Ventures web site underwent a minor update last week. We have simplified navigation within the site, hopefully making the things you’re looking for a little easier to find.

As always, we welcome your feedback. Send comments and suggestions to the e-mail link, below.